Laboratoire de Chimie de Coordination UPR 8241




Curriculum Vitae



Huang, D., Li, Y., Liu, Y., & Meunier, B. (2019). Synthesis and chelation selectivity evaluation of 8-aminoquinoline derivatives as copper chelator. Chin. J. Org. Chem., 39(2), 500–506.
Huang, J., Nguyen, M., Liu, Y., Robert, A., & Meunier, B. (2019). Synthesis and characterization of 8-aminoquinolines, substituted by electron donating groups, as high-affinity copper chelators for the treatment of Alzheimer's disease. C. R. Chimie, 22(5), 419–427.
Huang, J., Nguyen, M., Liu, Y., Robert, A., & Meunier, B. (2019). The TDMQ regulators of copper homeostasis do not disturb Cu,Zn-SOD and tyrosinase activity, nor the Cu(III) cofactor vitamin B12. Eur. J. Inorg. Chem., (10), 1384–1388.
Li, Y., Nguyen, M., Baudoin, M., Vendier, L., Liu, Y., Robert, A., & Meunier, B. (2019). Why is tetradentate coordination essential for potential copper homeostasis regulators in Alzheimer's disease? Eur. J. Inorg. Chem., 2019(44), 4712–4718.
Li, Y., Yan, L., Cai, J., Zhang, W., Li, L., Du, Z., Dong, C., Meunier, B., & Chen, H. (2019). Development of novel theranostic agents for in vivo amyloid imaging and protective effects on human neuroblastoma cells. Eur. J. Med. Chem., 181, 111585.
Liu, Y., Nguyen, M., Robert, A., & Meunier, B. (2019). Metal ions in Alzheimer’s disease: A key role or not? Acc. Chem. Res., 52(7), 2026–2035.
Meunier, B., & Robert, A. (2019). Comment on “Free-radical formation by the peroxidase-like catalytic activity of MFe2O4 (M = Fe, Ni, and Mn) nanoparticles”. J. Phys. Chem. C, 123(46), 28513–28514.
Yan, L., Deng, M., Chen, A., Li, Y., Zhang, W., Du, Z. - Y., Dong, C. - Z., Meunier, B., & Chen, H. (2019). Synthesis of N-pyrimidin[1,3,4]oxadiazoles and N-pyrimidin[1,3,4]-thiadiazoles from 1,3,4-oxadiazol-2-amines and 1,3,4-thiadiazol-2-amines via Pd-catalyzed heteroarylamination. Tetrahedron Lett., 60(20), 1359–1362.


Gumpelmayer, M., Nguyen, M., Molnar, G., Bousseksou, A., Meunier, B., & Robert, A. (2018). Magnetite Fe3O4 has no intrinsic peroxidase activity, and is probably not involved in Alzheimer's oxidative stress. Angew. Chem., Int. Ed., 57, 14758 –14763.
Meunier, B. (2018). Alzheimer : quand allons-nous avoir des médicaments efficaces ? Actualité Chimique, 433, 7.